AI Governance: Innovation, Privacy and the EU AI Act with Oliver Patel of AstraZeneca

Artificial intelligence is rapidly transforming the pharmaceutical and life sciences sector — but innovation in this field comes with some of the highest regulatory, ethical, and governance expectations.In this episode of Legal Leaders Insights from Diritto al Digitale, Giulio Coraggio of DLA Piper speaks with Oliver Patel, Head of Enterprise AI Governance at AstraZeneca, about how AI governance is implemented in practice within a global pharmaceutical company.The conversation covers:What enterprise AI governance looks like in the life sciences sectorHow to balance AI innovation with privacy, intellectual property, and complianceThe concrete implications of the EU AI Act for pharmaceutical companiesPractical governance approaches to enable responsible and scalable AIThis episode is particularly relevant for legal professionals, compliance teams, in-house counsel, data leaders, and executives working in highly regulated industries.Diritto al Digitale is the podcast where law, technology, and digital regulation intersect with real business challenges.Send us Fan Mail📌 You can find our contacts 👉 www.dlapiper.com